510(k) K131169
K131169 is an FDA 510(k) premarket notification submitted by Meril Life Sciences Private Limited for the device "MOZEC - RX PTCA BALLOON DILATATION CATHETER". The FDA issued a decision of Substantially Equivalent on Dec 24, 2013. The device falls under product code LOX (Catheters, Transluminal Coronary Angioplasty, Percutaneous), a Class II device regulated under 21 CFR 870.5100. Meril Life Sciences Private Limited has 3 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 24, 2013
- Date Received
- Apr 24, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Catheters, Transluminal Coronary Angioplasty, Percutaneous
- Device Class
- Class II
- Regulation Number
- 870.5100
- Review Panel
- CV
- Submission Type
- 510(k)
A PTCA catheter is a device that operates on the principle of hydraulic pressurization applied through an inflatable balloon attached to the distal end.